These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 16126322

  • 1. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH.
    Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
    [Abstract] [Full Text] [Related]

  • 2. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
    Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC.
    J Urol; 1999 Oct; 162(4):1337-40. PubMed ID: 10492192
    [Abstract] [Full Text] [Related]

  • 3. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.
    Cancer J Sci Am; 1998 Oct; 4(5):324-30. PubMed ID: 9815297
    [Abstract] [Full Text] [Related]

  • 4. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
    Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.
    J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
    Soergel TM, Koch MO, Foster RS, Bihrle R, Wahle G, Gardner T, Jung SH.
    J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
    [Abstract] [Full Text] [Related]

  • 9. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
    Nielsen ME, Makarov DV, Humphreys E, Mangold L, Partin AW, Walsh PC.
    Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
    [Abstract] [Full Text] [Related]

  • 10. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H.
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586
    [Abstract] [Full Text] [Related]

  • 13. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y.
    Eur Urol; 2006 Feb 01; 49(2):293-302. PubMed ID: 16387412
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.
    Urology; 2004 Jul 01; 64(1):84-9. PubMed ID: 15245941
    [Abstract] [Full Text] [Related]

  • 15. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
    Huland H, Hammerer P, Henke RP, Huland E.
    J Urol; 1996 Apr 01; 155(4):1344-7. PubMed ID: 8632570
    [Abstract] [Full Text] [Related]

  • 16. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
    Urology; 2004 Oct 01; 64(4):760-4. PubMed ID: 15491716
    [Abstract] [Full Text] [Related]

  • 17. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
    Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC.
    Urol Clin North Am; 1993 Nov 01; 20(4):713-25. PubMed ID: 7505980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.
    Eur Urol; 2009 Feb 01; 55(2):404-10. PubMed ID: 18639970
    [Abstract] [Full Text] [Related]

  • 20. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
    Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT.
    J Urol; 1995 Jan 01; 153(1):104-10. PubMed ID: 7526002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.